FOXO Technologies delisted from NYSE, begins trading on OTC

WEST PALM BEACH, Florida - FOXO Technologies Inc. (formerly NYSE:FOXO) has been delisted from the NYSE American exchange after its stock price fell below the minimum requirement of $0.10 per share on August 12, 2025, the company announced Wednesday. The stock has experienced a dramatic decline of over 98% year-to-date, according to InvestingPro data, with market capitalization now at just $930,000.

NYSE Regulation determined to commence delisting proceedings for FOXO’s Class A common stock pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price. Trading of the stock was immediately suspended following the price drop.

The company has received confirmation from FINRA’s Department of Market Operations that its common stock may be quoted and traded on the OTC market beginning August 13, 2025, under the same FOXO trading symbol.

"While we are disappointed that our share price has fallen below the $0.10 minimum requirement for continued listing on NYSE, this does not change the business strategy adopted or economic outlook for FOXO," said Seamus Lagan, Chief Executive Officer of FOXO.

The company stated it will consider options to potentially relist on NYSE or NASDAQ "at the appropriate time" and will remain compliant with SEC reporting requirements.

FOXO Technologies operates three subsidiaries: Rennova Community Health, which owns a critical access hospital in East Tennessee; Myrtle Recovery Centers, a 30-bed behavioral health facility; and FOXO Labs, a biotechnology company.

The information in this article is based on a company press release.

In other recent news, FOXO Technologies Inc. has implemented a 1-for-1.99 reverse stock split of its Class A Common Stock on the NYSE American. This action took effect at 4:01 p.m. Eastern Time on Sunday. Following the reverse stock split, every 1.99 shares of FOXO’s Class A Common Stock were consolidated into one issued and outstanding share. The company confirmed that the par value of $0.0001 per share remains unchanged. Additionally, FOXO Technologies addressed the issue of fractional shares by rounding up any fractional share entitlements to the nearest whole share. This strategic move aims to adjust the share structure without altering the overall value of the company’s stock. These developments highlight FOXO Technologies’ recent corporate actions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.